Kopran gets nod to sell its Consumer Care Division

15 Jul 2015 Evaluate

Kopran has received an approval for sale of Consumer Care Division with effect from April 01, 2015 along with all its assets and liabilities. The board of directors at their meeting held on July 14, 2015 has approved for the same.

Kopran is currently an integrated Pharmaceutical Company manufacturing a large range of products. It manufactures both Active Pharmaceutical Ingredients and Finished Dosage Forms.


Kopran Share Price

175.45 -5.85 (-3.23%)
09-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.10
Dr. Reddys Lab 1095.15
Cipla 1416.30
Lupin 1921.30
Zydus Lifesciences 844.60
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...